Skin Testing Prior to Measles Vaccination for Egg-Sensitive Patients
- 1 January 1990
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Pediatrics & Adolescent Medicine
- Vol. 144 (1) , 32
- https://doi.org/10.1001/archpedi.1990.02150250034026
Abstract
The recrudescence of measles and the recommended reimmunization of older children1 spotlights the problem of measles vaccination for the egg-sensitive patient. Measles vaccine (and mumps vaccine) is grown in chick embryo cell culture (not embryonated eggs), so there is a very low, but detectable, presence of egg-related antigens in the vaccine. In this issue of the AJDC, Dr Andrew Kemp and associates2 from Sydney, Australia, suggest that despite a history of immediate hypersensitivity reactions to egg protein, measles vaccine can be given safely without performing a vaccine skin test.3 Kemp et al make his recommendation based on the following facts:Keywords
This publication has 5 references indexed in Scilit:
- Measles Immunization in Children With Clinical Reactions to Egg ProteinArchives of Pediatrics & Adolescent Medicine, 1990
- Safe administration of mumps-measles-rubella vaccine in egg-allergic childrenThe Journal of Pediatrics, 1988
- Safe Immunization of Allergic Children Against Measles, Mumps, and RubellaArchives of Pediatrics & Adolescent Medicine, 1987
- Allergic reactions to measles (rubeola) vaccine in patients hypersensitive to egg proteinThe Journal of Pediatrics, 1983
- Severe Hypersensitivity or Intolerance Reactions to Measles Vaccine in Six Children Clinical and Immunological studiesAllergy, 1980